Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Cancer Survival Analysis01:21

Cancer Survival Analysis

345
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
345
Disorders of the Male Reproductive System01:20

Disorders of the Male Reproductive System

404
Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
404
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.6K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Extended endoscopic transnasal orbital decompression for dysthyroid optic neuropathy: efficacy and prognostic factors.

BMC ophthalmology·2026
Same author

Endoscopic transcervical mediastinal drainage for treating descending necrotizing mediastinitis.

BMC surgery·2026
Same author

Air pollution, socioeconomic status and the risk of incident rheumatic heart disease: a prospective cohort study.

BMC public health·2026
Same author

Vitamin D and Body Mass Index/Obesity in Postmenopausal Women: A Cross-Sectional Study With Analysis of the Atherogenic Index of Plasma as a Mediator.

The journal of obstetrics and gynaecology research·2026
Same author

Micropeptide YG-6 encoded by exosomal LINC01123 derived from highly migratory ovarian cancer cells promotes tumor progression.

Molecular cancer·2026
Same author

First application of the varipulse™ catheter for linear ablation in atrial fibrillation: a case report.

Frontiers in cardiovascular medicine·2026

相关实验视频

Updated: Jun 29, 2025

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

261

中国男性乳腺癌的临床特征和预后因素.

Han Lei1, Baojie Hua2, Yingying Mao2

  • 1The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine), Hangzhou, China.

Frontiers in oncology
|March 25, 2024
PubMed
概括
此摘要是机器生成的。

这项研究确定了年龄,瘤阶段和分化等级作为男性乳腺癌 (MBC) 的关键预后因素. 像LMR,PLR和NLR这样的炎症标志物显示出预测MBC结果的潜力.

关键词:
没有疾病的生存率.男性的乳腺癌是男性的乳腺癌.这个名字是名ogramogram.总体存活率 总体存活率预后 预后 预后

更多相关视频

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases
07:41

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases

Published on: May 17, 2019

9.0K
A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

13.1K

相关实验视频

Last Updated: Jun 29, 2025

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

261
Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases
07:41

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases

Published on: May 17, 2019

9.0K
A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

13.1K

科学领域:

  • 在瘤学瘤学.
  • 临床研究 临床研究
  • 癌症预后 癌症预后

背景情况:

  • 男性乳腺癌 (MBC) 是罕见的,需要研究其特定的临床特征和预后指标.
  • 了解影响MBC预后的因素对于定制治疗策略和改善患者治疗结果至关重要.

研究的目的:

  • 为了研究男性乳腺癌 (MBC) 患者的临床特征.
  • 确定预测男性乳腺癌预后的因素.

主要方法:

  • 追溯分析了2009年至2022年期间治疗的115例男性乳腺癌病例.
  • 利用考克斯的比例危险模型来确定总生存期 (OS) 和无病生存期 (DFS) 的预后因素.
  • 开发并验证了用于使用C指数和校准曲线预测DFS的诺姆图.

主要成果:

  • 诊断MBC的中位数年龄为59岁. 大多数病例是雌激素受体 (ER) 和孕激素受体 (PR) 阳性.
  • 淋巴细胞与单细胞的比率 (LMR),血小板与淋巴细胞的比率 (PLR) 和中性粒细胞与淋巴细胞的比率 (NLR) 与生存结果有关.
  • 年龄,组织学差异化等级和TNM阶段是DFS的显著预测因素,名图显示出良好的预测性表现 (C指数0.782).

结论:

  • 晚年,较大的瘤大小,较高的TNM阶段和较差的组织学差异化与更糟糕的MBC预后有关.
  • 炎症标志物,如LMR,PLR和NLR可能作为男性乳腺癌预后的潜在预测生物标志物.